MADISON HEIGHTS, Mich., June 1, 2016 /PRNewswire/ -- InfuSystem Holdings, Inc. (NYSE MKT: INFU), a leading national provider of infusion pumps and related services for the healthcare industry in the United States and Canada, today announced long-term payor agreements with one of the nation’s largest private insurance carriers, and with a prominent Midwest-based regional carrier. The multi-year payor agreement with the national health insurance carrier takes effect June 1, 2016, and includes coverage for the insurer’s individual, employer-sponsored, Medicare, and Medicaid members. The Midwest regional health carrier payor agreement went into effect on May 1, 2016 for enrolled members.
Eric K. Steen, chief executive officer of InfuSystem, said, “I am pleased with our newest contracted payor agreements creating in-network coverage on InfuSystem infusion pumps, supplies and 24/7 support service for members of these two large private insurers. Our joint goals are to deliver improved patient outcomes in the most accessible, effective and cost-efficient manner. Patients at InfuSystem’s customer facilities nationwide will have even more convenient and affordable in-network access to our services via our 400+ national, regional, and local payor networks.”
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. is a leading provider of infusion pumps and related services to hospitals, oncology practices and other alternate site healthcare providers. Headquartered in Madison Heights, Michigan, the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Texas, Georgia and Ontario, Canada. The Company’s stock is traded on the NYSE MKT under the symbol INFU.
Forward-Looking Statements
Certain statements contained in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “expect,” “strategy,” “future,” “likely,” variations of such words, and other similar expressions, as they relate to the Company, are intended to identify forward-looking statements. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. In connection with the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, the Company is identifying certain factors that could cause actual results to differ, perhaps materially, from those indicated by these forward-looking statements. Those factors, risks and uncertainties include, but are not limited to, potential changes in overall healthcare reimbursement, including CMS competitive bidding, sequestration, concentration of customers, increased focus on early detection of cancer, competitive treatments, dependency on Medicare Supplier Number, availability of chemotherapy drugs, global financial conditions, changes and enforcement of state and federal laws, natural forces, competition, dependency on suppliers, risks in acquisitions & joint ventures, U.S. Healthcare Reform, relationships with healthcare professionals and organizations, technological changes related to infusion therapy, dependency on websites and intellectual property, the ability of the Company to successfully integrate acquired businesses, dependency on key personnel, dependency on banking relations and covenants, and other risks associated with our common stock, as well as any litigation to which the Company may be involved in from time to time; and other risk factors as discussed in the Company’s annual report on Form 10-K for the year ended December 31, 2015 and in other filings made by the Company from time to time with the Securities and Exchange Commission, including our Form 10-Q for the first quarter of 2016. Our annual report on Form 10-K is available on the SEC’s EDGAR website at www.sec.gov, and a copy may also be obtained by contacting the Company. All forward-looking statements made in this press release speak only as of the date of this report. We do not intend, and do not undertake any obligation, to update any forward-looking statements to reflect future events or circumstances after the date of such statements.
Additional information about InfuSystem Holdings, Inc. is available at www.infusystem.com.
CONTACT: | Dorame, Joe Diaz & Robert Blum |
Lytham Partners, LLC | |
602-889-9700 |
Logo - http://photos.prnewswire.com/prnh/20160415/356049LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/infusystem-announces-two-long-term-payor-agreements-300277572.html
SOURCE InfuSystem Holdings, Inc.